Jacobson Pharma Dividends and Buybacks
Dividend criteria checks 4/6
Jacobson Pharma is a dividend paying company with a current yield of 8.43% that is well covered by earnings. Next payment date is on 2nd April, 2025 with an ex-dividend date of 25th February, 2025.
Key information
8.4%
Dividend yield
-2.0%
Buyback Yield
| Total Shareholder Yield | 6.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | 20.8% |
| Next dividend pay date | 02 Apr 25 |
| Ex dividend date | 25 Feb 25 |
| Dividend per share | HK$0.070 |
| Payout ratio | 50% |
Recent dividend and buyback updates
Recent updates
There's Reason For Concern Over Jacobson Pharma Corporation Limited's (HKG:2633) Massive 27% Price Jump
Nov 22
Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now
Aug 21Jacobson Pharma's (HKG:2633) Profits May Not Reveal Underlying Issues
Dec 21Jacobson Pharma's (HKG:2633) Dividend Is Being Reduced To HK$0.025
Nov 27These 4 Measures Indicate That Jacobson Pharma (HKG:2633) Is Using Debt Reasonably Well
Jun 20Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Nov 28Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.0268
Sep 25Should Shareholders Reconsider Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Package?
Sep 16Jacobson Pharma's (HKG:2633) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 28Jacobson Pharma's (HKG:2633) Upcoming Dividend Will Be Larger Than Last Year's
Jul 14Does Jacobson Pharma (HKG:2633) Have A Healthy Balance Sheet?
Feb 09Jacobson Pharma (HKG:2633) Is Increasing Its Dividend To HK$0.012
Nov 29Jacobson Pharma (HKG:2633) Is Reducing Its Dividend To HK$0.015
Sep 24Here's Why It's Unlikely That Jacobson Pharma Corporation Limited's (HKG:2633) CEO Will See A Pay Rise This Year
Sep 16Kwing Tong Lam Is The Independent Non-Executive Director of Jacobson Pharma Corporation Limited (HKG:2633) And They Just Picked Up 28% More Shares
Feb 03
A Look At The Fair Value Of Jacobson Pharma Corporation Limited (HKG:2633)
Jan 24Here's Why Jacobson Pharma (HKG:2633) Has A Meaningful Debt Burden
Jan 11Does Jacobson Pharma's (HKG:2633) CEO Salary Compare Well With The Performance Of The Company?
Dec 27Is It Smart To Buy Jacobson Pharma Corporation Limited (HKG:2633) Before It Goes Ex-Dividend?
Dec 12Reflecting on Jacobson Pharma's (HKG:2633) Share Price Returns Over The Last Three Years
Dec 03Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 2633 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 2633's dividend payments have increased, but the company has only paid a dividend for 8 years.
Dividend Yield vs Market
| Jacobson Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2633) | 8.4% |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Pharmaceuticals) | 3.8% |
| Analyst forecast (2633) (up to 3 years) | n/a |
Notable Dividend: 2633's dividend (8.43%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.3%).
High Dividend: 2633's dividend (8.43%) is in the top 25% of dividend payers in the Hong Kong market (8.09%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (50.2%), 2633's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (39.2%), 2633's dividend payments are well covered by cash flows.